Medicare Enrolled

Dr. Alexander Philipovskiy, M.D., PH.D

Medical Oncology · Lake Mary, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
805 CURRENCY CIR, Lake Mary, FL 32746
4078046133
In practice since 2010 (15 years)
NPI: 1598074544 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Philipovskiy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Philipovskiy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Philipovskiy

Dr. Alexander Philipovskiy is a medical oncology in Lake Mary, FL, with 15 years in practice. Based on federal Medicare data, Dr. Philipovskiy performed 1,367 Medicare services across 285 unique beneficiaries.

Between the years covered by Open Payments, Dr. Philipovskiy received a total of $6,735 from 45 pharmaceutical and/or device companies across 181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Philipovskiy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ Top 50% volume in FL$ $6,735 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,367
Medicare services
Top 50% in FL for medical oncology
285
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~91 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Dexamethasone injection (steroid)582$0$3
Blood draw (venipuncture)251$8$9
Complete blood count (CBC) with differential176$7$29
Administration of chemotherapy into vein, 1 hour or less123$93$378
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less82$22$84
Injection of additional new drug or substance into vein63$11$61
Drug injection, under skin or into muscle42$11$69
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less20$50$189
Office visit, established patient (30-39 min)15$98$339
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg13$1$6
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.5% high complexity
60.2% medium
32.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,735
Total received (2018-2024)
Avg $962/year across 7 years
Bottom 49% in FL for medical oncology
45
Companies
181
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,081 (90.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$654 (9.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,651
2023
$1,067
2022
$345
2021
$78
2020
$136
2019
$130
2018
$2,328

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Roche Products Limited
$2,198
GENZYME CORPORATION
$542
AstraZeneca Pharmaceuticals LP
$362
Novartis Pharmaceuticals Corporation
$358
Merck Sharp & Dohme LLC
$294
Incyte Corporation
$248
Lilly USA, LLC
$197
E.R. Squibb & Sons, L.L.C.
$186
BeiGene USA, Inc.
$185
Genentech USA, Inc.
$150
PFIZER INC.
$148
Janssen Biotech, Inc.
$145
Adaptive Biotechnologies Corporation
$136
Eisai Inc.
$130
Daiichi Sankyo Inc.
$128
Gilead Sciences, Inc.
$127
ABBVIE INC.
$98
Takeda Pharmaceuticals U.S.A., Inc.
$96
Ipsen Biopharmaceuticals, Inc
$85
Celgene Corporation
$85
ARRAY BIOPHARMA INC
$64
Genmab U.S., Inc.
$61
GlaxoSmithKline, LLC.
$59
JAZZ PHARMACEUTICALS INC.
$58
Seagen Inc.
$56
Pharmacyclics LLC, An AbbVie Company
$52
Alexion Pharmaceuticals, Inc.
$45
TerSera Therapeutics LLC
$44
SOBI, INC
$43
Mirati Therapeutics, Inc.
$38
Merck Sharp & Dohme Corporation
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Sun Pharmaceutical Industries Inc.
$29
Stemline Therapeutics Inc.
$25
TESARO, Inc.
$23
Acrotech Biopharma Inc.
$22
SpringWorks Therapeutics, Inc.
$22
MorphoSys, US Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$21
EMD Serono, Inc.
$20
Alnylam Pharmaceuticals Inc.
$18
Astellas Pharma US Inc
$15
Taiho Oncology, Inc.
$14
NOVARTIS PHARMACEUTICALS CORPORATION
$14
Verastem, Inc.
$11
Top 3 companies account for 46.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · BELEODAQ · BRAFTOVI · BRUKINSA · CALQUENCE · CERDELGA · CYRAMZA · Columvi · Copiktra · DOPTELET · Doptelet · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · REBLOZYL · RYBREVANT · SARCLISA · Stivarga · TAGRISSO · TALZENNA · TECENTRIQ · TUKYSA · Trodelvy · ULTOMIRIS · VERZENIO · Venclexta · XALKORI · XOSPATA · XTANDI · YONSA · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $493 per 100 Medicare services performed
Looking for a medical oncology in Lake Mary?
Compare medical oncologys in the Lake Mary area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
23
Per 100K population
4.8
County median income
$83,030
Nearest hospital
CENTRAL FLORIDA LAKE MONROE HOSPITAL
3.7 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Philipovskiy is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Philipovskiy experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Philipovskiy performed 582 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Philipovskiy receive payments from pharmaceutical companies?
Yes. Dr. Philipovskiy received a total of $6,735 from 45 companies across 181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Philipovskiy's costs compare to other medical oncologys in Lake Mary?
Dr. Philipovskiy's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Philipovskiy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →